Case Study: MET and ALK Targeted Therapies in NSCLC

onclivetv has 407 videos Subscribe Here

Description: Several novel targeted therapies are under investigation or are currently approved to treat patients with NSCLC. In this segment, panelists discuss MET and ALK inhibitors.

To view more from this discussion, visit
Shared By : onclivetv
Posted on : 09/20/13
Added : 6 years ago
Category : General